Expression and significance of p53 and mdm2 in patients with leukoplakia cancer

被引:0
|
作者
Juan-Juan Cui [1 ]
Xiao-Lan Han [1 ]
Wei-Min Wang [1 ]
机构
[1] Department of Stomatology,the First Affiliated Hospital of Anhui Medical University
关键词
Oral Leukoplakia; p53; mdm2; RT-PCR;
D O I
暂无
中图分类号
R739.8 [口腔、颌面部肿瘤];
学科分类号
100214 ;
摘要
Objective:To study the relationship of the expressions of p53 and mdm2 in leukoplakia cancer.Methods:RT-PCR was used to detect the mRNA of p53,mdm2 in patients with leukoplakia cancer.The frequencies of p53,mdm2 in peripheral blood were detected by flow cytometric analysis.Results:The expression of p53mRNA in normal oral mucosa,simple oral leukoplakia,no-simple oral leukoplakia and leukoplakia cancer were 7.7%,27.3%,33.3%,56.8%,respectively.The frequencies of p53 in normal oral mucosa,simple oral leukoplakia,no-simple oral leukoplakia and leukoplakia cancer were(0.3±0.1)%,(l.6±0.9)%,(1.9±1.1)%,(3.4±1.8)%.The expression of mdm2 mRNA in normal oral mucosa,simple oral leukoplakia,no-simple oral leukoplakia and leukoplakia cancer were 0.0%,6.8%,11.1%,37.8%,respectively.The frequencies of mdm2 in normal oral mucosa,simple oral leukoplakia,no-simple oral leukoplakia and leukoplakia cancer were(0.1±0.1)%,(0.8±0.6)%,(1.2±0.8)%,(1.2±0.8)%.There was a positively correlation between p53 mRNA and mdm2 mRNA.Conclusions:The positive rate of p53 and mdm2 cells in the peripheral blood increases in patients with leukoplakia cancer tissue and has positive correlation with the severity of leukoplakia cancer.
引用
收藏
页码:831 / 834
页数:4
相关论文
共 50 条
  • [21] p53 AND MDM2 PROTEIN EXPRESSION IN ACTINIC CHEILITIS
    Andrade de Freitas, Maria da Conceicao
    Pedreira Ramalho, Luciana Maria
    Aquino Xavier, Flavia Calo
    Gomes Moreira, Andre Luis
    Almeida Reis, Silvia Regina
    [J]. JOURNAL OF APPLIED ORAL SCIENCE, 2008, 16 (06) : 414 - 419
  • [22] The association between p53, MDM2, and MDM2 isoform C protein expression and survival in a multiethnic population of breast cancer patients
    Loo, Lenora W.
    Hernandez, Brenda Y.
    Shvetsov, Yurii
    Okoro, Danielle
    Gao, Chong
    Bargonetti, Jill
    [J]. CANCER RESEARCH, 2017, 77
  • [23] p53 and MDM2 isoforms in blood from lung cancer patients
    Gonzalez-Avila, Georgina
    Biol, Javier Delgado
    Martinez, Luis M.
    Ramos, Carlos
    Sommer, Bettina
    [J]. EXPERIMENTAL LUNG RESEARCH, 2007, 33 (05) : 245 - 258
  • [24] MDM2, MDMX and p53 in oncogenesis and cancer therapy
    Mark Wade
    Yao-Cheng Li
    Geoffrey M. Wahl
    [J]. Nature Reviews Cancer, 2013, 13 : 83 - 96
  • [25] Inorganic arsenic induces MDM2, p53, and their phosphorylation and affects the MDM2/p53 complex in vitro
    Yin, Jinyao
    Zhou, Qian
    Tan, Jingwen
    Che, Wangjun
    He, Yuefeng
    [J]. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2022, 29 (58) : 88078 - 88088
  • [26] MDM2, MDMX and p53 in oncogenesis and cancer therapy
    Wade, Mark
    Li, Yao-Cheng
    Wahl, Geoffrey M.
    [J]. NATURE REVIEWS CANCER, 2013, 13 (02) : 83 - 96
  • [27] Targeting the p53–MDM2 interaction to treat cancer
    C Klein
    L T Vassilev
    [J]. British Journal of Cancer, 2004, 91 : 1415 - 1419
  • [28] MDM2 inhibitors to reactivate p53 in human cancer
    Vassilev, L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S6 - S6
  • [29] p53 and MDM2 in the development and progression of bladder cancer
    SchmitzDrager, BJ
    Kushima, M
    Goebell, P
    Jax, TW
    Gerharz, CD
    Buttel, H
    Schulz, WA
    Ebert, T
    Ackermann, R
    [J]. EUROPEAN UROLOGY, 1997, 32 (04) : 487 - 493
  • [30] Inorganic arsenic induces MDM2, p53, and their phosphorylation and affects the MDM2/p53 complex in vitro
    Jinyao Yin
    Qian Zhou
    Jingwen Tan
    Wangjun Che
    Yuefeng He
    [J]. Environmental Science and Pollution Research, 2022, 29 : 88078 - 88088